Transgenic RNAi in mouse oocytes: a simple and fast approach to study gene function  by Stein, Paula et al.
Transgenic RNAi in mouse oocytes: a simple and fast approach
to study gene function
Paula Stein,1 Petr Svoboda,1 and Richard M. Schultz*
Department of Biology, University of Pennsylvania, Philadelphia, PA 19104-6018, USA
Received for publication 21 November 2002, revised 12 December 2002, accepted 13 December 2002
Abstract
Double-strand RNA (dsRNA)-mediated posttranscriptional gene silencing, also known as RNA interference (RNAi), is a powerful tool
to inhibit gene expression in several experimental model systems, including Arabidopsis, Caenorhabditis, and Drosophila. We previously
described that the microinjection of Mos dsRNA into fully grown mouse oocytes results in the specific degradation of Mos mRNA in a time-
and concentration-dependent manner. We report here a transgenic RNAi approach that is suitable to study gene function during mouse
oocyte development and differentiation. The oocyte-specific Zp3 promoter was used to drive the expression of a long hairpin dsRNA (500
bp) targeting Mos mRNA. Transgenic founder animals appeared healthy, but while males were fertile, females were not, in accordance with
the known Mos null phenotype. The amount of Mos mRNA in the transgenic F1 females was reduced by 90%, whereas there was no
decrease in the nontargeted tissue plasminogen activator (Plat) mRNA. Moreover, the maturation-associated increase in mitogen-activated
protein (MAP) kinase activity was not observed, and the metaphase II eggs underwent spontaneous parthenogenetic activation, thus
recapitulating the Mos null phenotype. This approach provides a powerful method to study the functions of any oocyte-synthesized gene
during oocyte development and early embryogenesis.
© 2003 Elsevier Science (USA). All rights reserved.
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Introduction
The holy grail of modern biology is to understand the
function of each gene in the genome in every tissue/cell
type. Disrupting a gene by homologous recombination is a
standard approach to deduce gene function. Nevertheless,
this approach is fraught with problems when studying gene
function in oocytes, the female germ cells, since it can be
difficult generating oocytes that are deficient in both alleles.
For example, if the gene of interest is not oocyte-specific,
the homozygous null mutant may be an embryonic lethal.
Although Cre-lox technology can be used to study gene
function in oocytes (de Vries et al., 2000), the approach is
not without its own intrinsic problems, and moreover, it is
labor intensive.
An alternative method to study gene function in oocytes
has been to use a transgenic antisense approach. Driving the
expression of an antisense RNA to Plat (tissue plasminogen
activator, tPA) with the oocyte-specific Zp3 promoter re-
sulted in a reduction in Plat enzyme activity that ranged
from 19 to 37% in hemizygous transgenic females to 60% in
homozygous transgenic mice (Richards et al., 1993). Al-
though antisense transgenes have been used with various
success in several different tissues (reviewed in Erickson,
1999), the mechanism of their action was never fully un-
derstood. The recently discovered phenomenon of RNA
interference (RNAi), a conserved cellular mechanism pro-
moting sequence-specific mRNA degradation triggered by
double-strand RNA (dsRNA), provides an explanation for
the effect of antisense transgenes on the mRNA level and
simultaneously allows the design of a more efficient post-
transcriptional gene targeting system. The antisense RNA
presumably pairs with the sense mRNA target to form a
dsRNA that triggers the degradation of mRNA by the RNAi
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pathway. In fact, nuclear formation of dsRNA in antisense
transgenes was described (Kim and Wold, 1985; Okano et
al., 1991) long before the discovery of RNAi. The involve-
ment of RNAi implies that the decrease of mRNA by
antisense RNA depends on the efficient formation of the
dsRNA trigger, its length, and the efficiency of the RNAi
machinery in the tissue of interest. In fact, the length of the
targeting sequence and high level of expression were pre-
viously recognized as important factors for successful anti-
sense approach (Erickson, 1999). Likewise, we have found
that RNAi is at least a hundred times more efficient than
antisense RNA in mouse oocytes, suggesting that the direct
expression of dsRNA via a transgenic approach should
induce much more efficient gene repression than a trans-
genic antisense RNA approach (Svoboda et al., 2000).
Successful transgenic RNAi where the dsRNA trigger is
expressed from a transgene has been reported in Caeno-
rhabditis elegans (Tavernarakis et al., 2000), Drosophila
(Kennerdell and Carthew, 2000), and Arabidopsis (Chuang
and Meyerowitz, 2000) but not in mammals. Constructs
expressing dsRNA usually contain an inverted repeat (IR)
that is transcribed from a single promoter following the
design of the first transgenic RNAi in C. elegans (Tavern-
arakis et al., 2000), but dual promoter systems also work
(Timmons and Fire, 1998; Wang et al., 2000).
We report here the first successful use of transgenic
RNAi in mammals in which the Mos gene was targeted by
dsRNA expressed in a form of long hairpin RNA from the
Zp3 promoter. Oocytes that express the transgene exhibit
the phenotype of the Mos null mutant, namely, that the
maturation-associated increase in mitogen-activated protein
(MAP) kinase activity is not observed and the oocytes
undergo spontaneous parthenogenetic activation at a high
frequency. This approach provides a powerful method to
study the functions of any oocyte-synthesized gene during
oocyte development and early embryogenesis.
Materials and methods
Transgene preparation, generation of transgenic animals,
and genotyping of transgenic mice
Construction of the plasmid carrying the transgenic con-
struct expressing 0.5 kb Mos RNA hairpin from the oo-
cyte-specific Zp3 promoter (Fig. 1A) has been described
elsewhere (Svoboda et al., 2001). About 5 g of the plasmid
were cut with AseI and AflII restriction endonucleases, and
the products were resolved in a 0.7% agarose gel. The band
corresponding to the expression cassette was purified from
the gel by using Qiagen Gel Extraction Kit (Qiagen, CA)
according to the manufacturer’s instructions. DNA was
eluted from Qiagen columns by using sterile MilliQ water,
and its concentration was estimated spectrophotometrically.
The DNA was diluted to 5 ng/l in sterile MilliQ water and
submitted to the Transgenic and Chimeric Mouse Facility
(TCMF) at the University of Pennsylvania to generate trans-
genic animals in B6SJLF1/J mice.
Southern blot and PCR analyses were used to identify
transgenic mice. DNA was isolated by using proteinase K
digestion followed by phenol extraction using TCMF’s proto-
col (www.uphs.upenn.edu/genetics/core-facs/tcmf/). South-
ern blotting and hybridization were performed by standard
methods (Ausubel et al., 1989). For PCR screening, we used
primers generating a 301-bp product that spanned the intron
(Fig. 1A). Genomic DNA (0.5 l containing 100–400
ng of DNA) was used in a 25-l PCR. Primer sequences
were 5-GCCTGGTGCTACGCCTGAATAA-3 for for-
ward primer, and 5-GTCAGCAGTAGCCTCATCATC-3
for reverse primer. PCR was performed with Amplitaq Gold
(Applied Biosystems, CA) as follows: an initial denatur-
ation step at 94° C for 15 min followed by 36 cycles of 94°
C for 30 s, 58° C for 30 s, and 72° C for 30 s followed by
4° C until samples were removed.
Oocyte collection and in vitro maturation
Fully grown, germinal vesicle-intact (GV) mouse oo-
cytes were obtained from 4-week-old female mice and freed
Fig. 1. Transgenic construct and its expression. (A) Structure of the trans-
genic construct. Arrowheads depict positions of primers IF and IR used
for genotyping and expression analysis. Mos IR, Mos inverted repeat;
EGFP, enhanced green fluorescent protein. (B) Expression of the trans-
gene. Lane 1 is a 1-kb DNA ladder. Lanes 2–4, RT-PCR analysis of fully
grown oocytes from F1 animals of the H13 male founder. The presence of
the 267-bp spliced PCR product confirms the expression of the transgene
in the transgenic animals 1 and 7, whereas it is absent in the nontransgenic
littermate 5. Lane 5, blank. Lane 6, the 301-bp unspliced product amplified
from the genomic DNA of founder H13.
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of attached cumulus cells as previously described (Schultz
et al., 1983). The collection medium was bicarbonate-free
minimal essential medium (Earle’s salts) supplemented with
polyvinylpyrrolidone (3 mg/ml) and 25 mM Hepes, pH 7.3.
The denuded oocytes were matured in CZB medium (Chatot
et al., 1989) in an atmosphere of 5% CO2 in air at 37°C. For
kinase assays (see below), some oocytes were removed and
lysed individually after 18 h of culture. The remaining
oocytes were further cultured to assess parthenogenetic ac-
tivation. Images were captured by using a Leica DMIL
inverted microscope and an Optronics MagnaFire CCD
camera.
RNA isolation and semiquantitative RT-PCR
RNA was isolated from fully grown oocytes as described
previously (Temeles et al., 1994). Semiquantitative RT-
PCR analysis of Mos and Plat was performed as described
previously (Svoboda et al., 2000). The same cDNA was also
used to detect the expression of the spliced intron using
primers and conditions described above.
Histone H1 and MAP kinase assay
Histone H1 and MAP kinase activities were assayed in
single oocytes as described previously (Svoboda et al.,
2000). MAP kinase activity serves as an indirect measure of
the MOS kinase (Svoboda et al., 2000), and H1 kinase
activity is a marker for CDK1/CYCB activity. Each of these
activities increases during oocyte maturation, and H1 kinase
serves as a biochemical marker for egg activation, since it
decreases following activation (Moos et al., 1995).
Results
Rationale for the experimental design
Mos codes for a serine–threonine kinase that functions
upstream of MAP kinase. Mos mRNA is an abundant (104
transcripts in a fully grown, GV oocyte) dormant message
that accumulates during oocyte growth and is not translated
until resumption of meiosis. Mobilization of Mos mRNA
results in the activation of MAP kinase, whose activity is
required to maintain cell cycle arrest at metaphase II (Ge-
bauer and Richter, 1997; Sagata, 1997). The Mos model
system provides two features that are useful to evaluate a
transgenic RNAi approach. The first is that oocytes lacking
the Mos gene do not arrest at metaphase II but undergo
spontaneous parthenogenetic activation that is a readily ob-
served phenotype as evidenced by emission of the second
polar body, pronucleus formation, and cleavage (Colledge
et al., 1994; Hashimoto et al., 1994; Hirao and Eppig, 1997).
Second, the amount of MAP kinase activity is a simple
indirect assay for Mos mRNA level because Mos mRNA is
not translated until oocytes resume meiosis. Moreover, the
ability to measure MAP kinase activity in single oocytes/
eggs provides a simple way to assess the uniformity of the
transgenic RNAi effect.
Classification of transgenic animals
Sixty-eight mice were obtained after pronuclear micro-
injection of one-cell embryos, and Southern blot and PCR
analyses of tail DNA samples identified nine transgenic
founder mice (Table 1). Female founders were repeatedly
mated for at least 3 months in an attempt to obtain F1
transgenic progeny before sacrificing them to analyze their
oocytes. Male founders were mated to CF-1 females, the
progeny were tested for transmission of the transgene, and
transgenic F1 females were then screened for the Mos phe-
notype (Table 1). The presence and expression of the trans-
gene in F1 animals was detected by RT-PCR (Fig. 1B).
Analysis of founder animals
The transgenic founders appeared normal, except that
two of the three transgenic females did not produce any
progeny after repeated matings, in agreement with the pre-
viously reported subfertility of the Mos null mice where
40% of the females were infertile while the remainder were
significantly subfertile (Hashimoto et al., 1994).
The two founder females (H59 and H54), which did not
produce any progeny, were sacrificed, and oocytes were
collected and matured in vitro. These oocytes progressed to
metaphase II and then underwent parthenogenetic activation
at a high incidence when compared with a nontransgenic
sibling (H70) (Fig. 2). Also consistent with the Mos null
Table 1
Characterization of transgenic founders
Animal Sex Copy number
estimation
Transmission Phenotype
C679 H6 M single YES NO
C679 H13 M low YES YES (in F1)
C679 H21 M single NO —
C679 H41 F single NO —
C679 H53 M low YES YES (in F1)
C679 H54 F high no progeny YES (founder)
C679 H56 M single YES* N.D.
C679 H59 F low no progeny YES (founder)
C679 H63 M single YES NO
Note. The C679 code is omitted when referring to transgenic founders in
this paper. Copy number estimates are based on Southern blot analysis.
Low copy, 2–3 copies are in a tandem array; high copy, 5 copies are
likely in a tandem array. Transmission describes whether the transgene was
transmitted to the next generation. * , Transgenic F1 females were not
obtained; no progeny, these two transgenic females did not produce any
progeny after repeated mating for at least 3 months. Phenotype indicates if
some phenotype (low MAP kinase activity, parthenogenetic activation)
was present in founder females or in transgenic F1 female progeny.
N.D., not determined, because no female progeny were obtained from
this male.
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phenotype was that the maturation-associated increase in
MAP kinase activity was not observed when some of these
matured oocytes were analyzed (data not shown).
Analysis of F1 transgenic females
Among the six transgenic males, five transmitted the
transgene to the F1 generation, and matured oocytes from F1
female progeny of two of them, H13 and H53, displayed a
low level of MAP kinase activity (Fig. 3A; Table 1). This
decrease in MAP kinase activity suggested an efficient tar-
geting of Mos mRNA in these animals. Semiquantitative
RT-PCR analysis of oocytes obtained from F1 progeny of
H13 and H53 revealed up to a 98% reduction of Mos mRNA
(Fig. 4). This reduction was specific, since there was no
apparent decrease in the amount of the nontargeted Plat
mRNA. The substantial reduction in Mos mRNA in these
eggs correlated well with the observation that all the eggs
obtained from H13 F1 female progeny exhibited a very low
level of MAP kinase and H1 kinase activities in MII eggs
(Fig. 3). Consistent with the low H1 kinase activity was that
84% of these eggs (38/45) underwent parthenogenetic acti-
vation following culture and either formed pronuclei (Fig.
5A) or cleaved to the two-cell stage or beyond (Fig. 5B). In
contrast, eggs obtained from nontransgenic littermates ei-
ther remained at MII (12/16) (Fig. 5C) or underwent frag-
mentation (Fig. 5D) after 65 h in culture. We did not
observe a dramatic incidence of fragmentation in transgenic
animals (2/25) after such an extended culture. This differs
from a previous report (75% fragmentation) (Colledge et al.,
1994) and may reflect differences in the genetic back-
grounds of strains used.
Compared with H13 female progeny, the amount of Mos
mRNA in H53 F1 female progeny was less (Fig. 4) and
MAP kinase activity was not as low (19 vs 11%, P value 
0.01, t test). These eggs displayed no apparent decrease in
H1 kinase and as expected did not undergo parthenogenetic
activation (data not shown). Thus, only a small additional
decrease in MAP kinase activity is sufficient to trigger
parthenogenetic activation.
Discussion
The transgenic RNAi approach reported here should be a
powerful method to study the function of any gene in the
oocyte and has several advantages when compared with
existing methods. The first advantage is that it is relatively
simple, since it only entails generating transgenic mice in
which the transgene is maintained in males that can be
repeatedly mated to obtain enough transgenic females for
subsequent analysis. This overcomes the common problem
when the gene of interest has an embryonic lethal pheno-
type, thereby dictating the use of the more complicated
Cre-lox approach. The highly efficient lentiviral vector ap-
proach, which doesn’t entail pronucleus injection (Lois et
al., 2002), to generate transgenic mice may make this trans-
genic RNAi approach even simpler.
Another significant feature of this knockdown approach
is that RNAi could generate a range of informative pheno-
types that complements the “classical” gene knockout ap-
proach, since hypomorph phenotypes frequently provide
critical insights into gene function. For example, an allelic
series of mutations in Smad2 and Smad4 reveals a range of
phenotypes in this signaling pathway (Vivian et al., 2002).
Moreover, a knockdown approach can unmask the existence
of a threshold level of gene function required to observe a
mutant phenotype. For example, we report here that oocytes
from nonmosaic females in two transgenic lines (H13 and
H53) exhibit a dramatic reduction in Mos mRNA, and yet
these lines show markedly different phenotypes. The line
that exhibits the greater decrease in Mos mRNA (H13)
Fig. 2. Parthenogentic activation of eggs from a transgenic animal. (A)
Parthenogenetic activation of MII eggs from female founder H54 as evi-
denced by pronucleus formation (arrow) and cleavage. (B) MII eggs from
the nontransgenic sibling H70 remain arrested at methaphase II. The
arrowhead depicts a fragmented egg.
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reveals a lower level of MAP kinase activity (11% when
compared with controls, i.e., an 89% decrease) and also
exhibits a relatively uniform and low level of H1 kinase
activity, consistent with the observed high increase in the
incidence of parthenogenetic activation. Although the other
line (H53) also displays a significant reduction in MAP
kinase (19% when compared with controls, i.e., an 81%
decrease), there is no reduction in H1 kinase activity or any
sign of parthenogenetic activation. These results reveal a
threshold level of MAP kinase that must be present to
maintain metaphase II arrest. Detecting thresholds provides
insights into how a cellular switch may function (Ferrell,
1999a,b). That modest changes in the expression of a gene
can result in profound differences in outcome is highlighted
by the observation that changes of 50% in the levels of
Oct-4 expression function as a developmental switch by
regulating the fate of ES cells, e.g., higher levels lead to
differentiation into primitive endoderm and mesoderm, in-
termediate levels lead to pluripotent stem cells, and reduced
levels result in trophectoderm (Niwa et al., 2000). By ex-
perimentally manipulating the level of expression of the
hairpin RNA via differences in transgene number or pro-
moter design, it should be possible to generate informative
allelic series that will reveal insights into the gene’s func-
tion.
There are two concerns that should be considered when
expressing long dsRNA. First, expression of RNA that can
form a hairpin can be compromised by activation of cryptic
splicing sites and polyadenylation signals in the antisense
sequence. Computational analysis and testing the antisense
strand in an exon trapping system (Hamaguchi et al., 1992;
Ozawa et al., 1993) may be helpful to avoid this problem.
Second, cloning the inverted repeat for expression of long
hairpin dsRNA is often difficult for reasons that remain
poorly understood, but may be related to difficulty in rep-
licating inverted repeat DNA (Tavernarakis et al., 2000;
Svoboda et al., 2001). A solution to this problem can be
using an intron spacer that greatly enhances cloning and
Fig. 3. Analysis of transgenic F1 generation. (A) MAP and H1 kinase assay on metaphase II eggs from progeny of male founders H53 and H13. Representa-
tive examples of phosphorimager scans are shown. Each lane represents one egg. TG, transgenic littermate; NTG, nontransgenic littermate. (B) Quanti-
fication of all data obtained by dual kinase assays from H53 and H13 progeny. Kinase activities from MII eggs obtained from F1 transgenic animals
are expressed relative to MII eggs obtained from their nontransgenic littermates. Solid bars, relative MAP kinase activity; open bars, relative H1 kinase
activity. The data are expressed as the mean  S.E.M. The absence of an error bar in the experimental groups indicates that the error was too small to be
observed.
Fig. 4. Semiquantitative RT-PCR analysis of Mos and Plat mRNA in
oocytes obtained from transgenic F1 animals. Phosphorimager scans show
the relative Mos mRNA levels in nontransgenic (H53/3, H13/5) and trans-
genic (H53/4, H13/1, H13/7) progeny of male founders H53 and H13. Plat
is a nontargeted mRNA that serves as an internal control.
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produces very efficient loop-less RNA hairpins (Kalidas and
Smith, 2002; Smith et al., 2000; Wesley et al., 2001).
The transgenic RNAi approach described here is likely
much more efficient than the previously reported transgenic
antisense method. The transcript abundance for both Mos
and Plat is similar, and yet the inhibitory effect observed in
hemizygous oocytes is much stronger when Mos mRNA is
targeted by RNAi than when Plat mRNA was targeted by
antisense RNA. The difference in efficiency is likely under-
estimated. In the transgenic antisense study, the entire Zp3
promoter was used, and the Zp3 3 UTR and polyadenyla-
tion signal were present. Our construct uses a truncated
version of this promoter, which, although it still exhibits
oocyte-specific expression, may drive lower levels of ex-
pression due to the absence of particular regulatory ele-
ments. Moreover, our construct contains an SV40 early
polyadenylation signal and the SV40 small intron. We have
discovered recently that this construct exhibits about an
order of magnitude lower expression compared with a con-
struct with a different intron and SV40 late polyadenylation
signal (data not shown).
Since Mos mRNA accumulates during oocyte growth
and is not translated until resumption of meiosis, it is subject
to RNAi throughout the growth phase. Thus, it is possible
that the approach described here could only be applicable to
similar types of maternally repressed mRNAs. We believe
that this is most unlikely. In the female, MSY2 is an oocyte-
specific RNA-binding protein that is expressed throughout
oocyte growth and is one of the most abundant proteins in
oocytes, comprising 2% of total oocyte protein (Yu et al.,
2001). We have used a similar transgenic RNAi approach to
target Msy2 and find that the amount of MSY2 protein is
selectively reduced and that the female transgenic mice
display a marked reduction in fertility (Yu, Hecht, and
R.M.S., unpublished results). Although this transgenic
RNAi approach would be ineffective in studying genes in
oocytes of primordial follicles in which the Zp3 promoter is
not yet activated, using a primodial oocyte-specific pro-
moter would circumvent this problem.
The oocyte is ideally suited for this transgenic RNAi
approach that results in the expression of a long dsRNA. In
contrast to somatic cells that typically undergo apoptosis
when exposed to dsRNA 30 bp (Castelli et al., 1997; Der
et al., 1997), long dsRNA apparently does not trigger apo-
ptosis in either oocytes or preimplantation embryos, which
do contain the cell death machinery (Brison and Schultz,
1997; Jurisicova et al., 1998; Morita and Tilly, 1999).
Whether the approach can be translated to target genes in
other cell types by using a tissue-specific promoter remains
to be established. Of potential interest is that dsRNA can be
expressed in somatic cells without apparently triggering
apoptosis (de Wit et al., 2002; Gan et al., 2002; Kantarjian
et al., 1985; Kim and Wold, 1985; Kramerov et al., 1985;
Okano et al., 1991; Schmitt et al., 1986).
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